HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Carson

This article was originally published in The Rose Sheet

Executive Summary

Anticipates taking $14.1 mil. loss in fourth quarter in connection with the sale of Cutex nail polisher remover and nail implements business to The Cutex Company, Carson reports in Dec. 24 8-K filing with the Securities & Exchange Commission. The ethnic marketer sold intellectual property, inventory and equipment to the San Francisco-based start-up for $30 mil. Dec. 9 ("The Rose Sheet" Dec. 14, 1998, In Brief). Under the deal, The Cutex Company retains the option of purchasing the Cutex nail enamel and treatment business, on or before June 9. Carson has said it does not view Cutex as a strategic part of the company's business and put the brand up for sale in June ("The Rose Sheet" June 8, 1998, p. 3)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006152

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel